Association between ADIPOQ SNPs with plasma adiponectin and glucose homeostasis and adiposity phenotypes in the IRAS Family Study

Molecular Genetics and Metabolism

Volumn 107, Issue 4, 2012, Pages 721-728

  An, S Sandy ^a   Hanley, Anthony J G ^b   Ziegler, Julie T ^a   Brown, W Mark ^a   Haffner, Steven M ^c   Norris, Jill M ^d   Rotter, Jerome I ^e   Guo, Xiuqing ^e   Chen, Y D Ida ^e   Wagenknecht, Lynne E ^a   Langefeld, Carl D ^a   Bowden, Donald W ^a   Palmer, Nicholette D ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d Global Health and Health Disparities   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Adiponectin; Adiposity; African Americans; Glucose homeostasis; Hispanic Americans; Single nucleotide polymorphisms

Indexed keywords

ADIPONECTIN; GLUCOSE;

ADIPOQ GENE; ADULT; AFRICAN AMERICAN; ARTICLE; FEMALE; GENE; GENETIC VARIABILITY; GLUCOSE HOMEOSTASIS; HISPANIC; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPONECTIN; ADIPOSITY; ADULT; AFRICAN AMERICANS; ALLELES; FEMALE; GENETIC ASSOCIATION STUDIES; GLUCOSE; HISPANIC AMERICANS; HOMEOSTASIS; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84869861770     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2012.10.003     Document Type: Article

References (40)

1. Fruebis J., Tsao T.S., Javorschi S., Ebbets-Reed D., Erickson M.R., Yen F.T., Bihain B.E., Lodish H.F. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:2005-2010.
2. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., Iwahashi H., Kuriyama H., Ouchi N., Maeda K., Nishida M., Kihara S., Sakai N., Nakajima T., Hasegawa K., Muraguchi M., Ohmoto Y., Nakamura T., Yamashita S., Hanafusa T., Matsuzawa Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 2000, 20:1595-1599.
3. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 1999, 257:79-83.
4. Yamamoto Y., Hirose H., Saito I., Tomita M., Taniyama M., Matsubara K., Okazaki Y., Ishii T., Nishikai K., Saruta T. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin. Sci. (Lond.) 2002, 103:137-142.
5. Scherer P.E., Williams S., Fogliano M., Baldini G., Lodish H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 1995, 270:26746-26749.
6. Adamczak M., Wiecek A., Funahashi T., Chudek J., Kokot F., Matsuzawa Y. Decreased plasma adiponectin concentration in patients with essential hypertension. Am. J. Hypertens. 2003, 16:72-75.
7. Ohashi K., Kihara S., Ouchi N., Kumada M., Fujita K., Hiuge A., Hibuse T., Ryo M., Nishizawa H., Maeda N., Maeda K., Shibata R., Walsh K., Funahashi T., Shimomura I. Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 2006, 47:1108-1116.
8. Matsubara M., Maruoka S., Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J. Clin. Endocrinol. Metab. 2002, 87:2764-2769.
9. Comuzzie A.G., Funahashi T., Sonnenberg G., Martin L.J., Jacob H.J., Black A.E., Maas D., Takahashi M., Kihara S., Tanaka S., Matsuzawa Y., Blangero J., Cohen D., Kissebah A. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J. Clin. Endocrinol. Metab. 2001, 86:4321-4325.
10. Hivert M.F., Manning A.K., McAteer J.B., Florez J.C., Dupuis J., Fox C.S., O'Donnell C.J., Cupples L.A., Meigs J.B. Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: the Framingham Offspring Study. Diabetes 2008, 57:3353-3359.
11. Vasseur F., Helbecque N., Lobbens S., Vasseur-Delannoy V., Dina C., Clement K., Boutin P., Kadowaki T., Scherer P.E., Froguel P. Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ACDC) gene promoter variants in morbid obesity: evidence for a role of ACDC in diabesity. Diabetologia 2005, 48:892-899.
12. Yang W.S., Hsiung C.A., Ho L.T., Chen Y.T., He C.T., Curb J.D., Grove J., Quertermous T., Chen Y.D., Kuo S.S., Chuang L.M. Genetic epistasis of adiponectin and PPARgamma2 genotypes in modulation of insulin sensitivity: a family-based association study. Diabetologia 2003, 46:977-983.
13. Dastani Z., Hivert M.F., Timpson N., Perry J.R., Yuan X., Scott R.A., Henneman P., Heid I.M., Kizer J.R., Lyytikainen L.P., Fuchsberger C., Tanaka T., Morris A.P., Small K., Isaacs A., Beekman M., Coassin S., Lohman K., Qi L., Kanoni S., Pankow J.S., Uh H.W., Wu Y., Bidulescu A., Rasmussen-Torvik L.J., Greenwood C.M., Ladouceur M., Grimsby J., Manning A.K., Liu C.T., Kooner J., Mooser V.E., Vollenweider P., Kapur K.A., Chambers J., Wareham N.J., Langenberg C., Frants R., Willems-Vandijk K., Oostra B.A., Willems S.M., Lamina C., Winkler T.W., Psaty B.M., Tracy R.P., Brody J., Chen I., Viikari J., Kahonen M., Pramstaller P.P., Evans D.M., St Pourcain B., Sattar N., Wood A.R., Bandinelli S., Carlson O.D., Egan J.M., Bohringer S., van Heemst D., Kedenko L., Kristiansson K., Nuotio M.L., Loo B.M., Harris T., Garcia M., Kanaya A., Haun M., Klopp N., Wichmann H.E., Deloukas P., Katsareli E., Couper D.J., Duncan B.B., Kloppenburg M., Adair L.S., Borja J.B., Wilson J.G., Musani S., Guo X., Johnson T., Semple R., Teslovich T.M., Allison M.A., Redline S., Buxbaum S.G., Mohlke K.L., Meulenbelt I., Ballantyne C.M., Dedoussis G.V., Hu F.B., Liu Y., Paulweber B., Spector T.D., Slagboom P.E., Ferrucci L., Jula A., Perola M., Raitakari O., Florez J.C., Salomaa V., Eriksson J.G., Frayling T.M., Hicks A.A., Lehtimaki T., Smith G.D., Siscovick D.S., Kronenberg F., van Duijn C., Loos R.J., Waterworth D.M., Meigs J.B., Dupuis J., Richards J.B. Novel Loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet. 2012, 8:e1002607.
14. Guo X., Saad M.F., Langefeld C.D., Williams A.H., Cui J., Taylor K.D., Norris J.M., Jinagouda S., Darwin C.H., Mitchell B.D., Bergman R.N., Sutton B., Chen Y.D., Wagenknecht L.E., Bowden D.W., Rotter J.I. Genome-wide linkage of plasma adiponectin reveals a major locus on chromosome 3q distinct from the adiponectin structural gene: the IRAS family study. Diabetes 2006, 55:1723-1730.
15. Lindsay R.S., Funahashi T., Krakoff J., Matsuzawa Y., Tanaka S., Kobes S., Bennett P.H., Tataranni P.A., Knowler W.C., Hanson R.L. Genome-wide linkage analysis of serum adiponectin in the Pima Indian population. Diabetes 2003, 52:2419-2425.
16. Ling H., Waterworth D.M., Stirnadel H.A., Pollin T.I., Barter P.J., Kesaniemi Y.A., Mahley R.W., McPherson R., Waeber G., Bersot T.P., Cohen J.C., Grundy S.M., Mooser V.E., Mitchell B.D. Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS Study. Obesity (Silver Spring) 2009, 17:737-744.
17. Heid I.M., Henneman P., Hicks A., Coassin S., Winkler T., Aulchenko Y.S., Fuchsberger C., Song K., Hivert M.F., Waterworth D.M., Timpson N.J., Richards J.B., Perry J.R., Tanaka T., Amin N., Kollerits B., Pichler I., Oostra B.A., Thorand B., Frants R.R., Illig T., Dupuis J., Glaser B., Spector T., Guralnik J., Egan J.M., Florez J.C., Evans D.M., Soranzo N., Bandinelli S., Carlson O.D., Frayling T.M., Burling K., Smith G.D., Mooser V., Ferrucci L., Meigs J.B., Vollenweider P., Dijk K.W., Pramstaller P., Kronenberg F., van Duijn C.M. Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals. Atherosclerosis 2010, 208:412-420.
18. Bostrom M.A., Freedman B.I., Langefeld C.D., Liu L., Hicks P.J., Bowden D.W. Association of adiponectin gene polymorphisms with type 2 diabetes in an African American population enriched for nephropathy. Diabetes 2009, 58:499-504.
19. Mori Y., Otabe S., Dina C., Yasuda K., Populaire C., Lecoeur C., Vatin V., Durand E., Hara K., Okada T., Tobe K., Boutin P., Kadowaki T., Froguel P. Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate Loci on 7p and 11p. Diabetes 2002, 51:1247-1255.
20. Vasseur F., Helbecque N., Dina C., Lobbens S., Delannoy V., Gaget S., Boutin P., Vaxillaire M., Lepretre F., Dupont S., Hara K., Clement K., Bihain B., Kadowaki T., Froguel P. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum. Mol. Genet. 2002, 11:2607-2614.
21. Kissebah A.H., Sonnenberg G.E., Myklebust J., Goldstein M., Broman K., James R.G., Marks J.A., Krakower G.R., Jacob H.J., Weber J., Martin L., Blangero J., Comuzzie A.G. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:14478-14483.
22. Henkin L., Bergman R.N., Bowden D.W., Ellsworth D.L., Haffner S.M., Langefeld C.D., Mitchell B.D., Norris J.M., Rewers M., Saad M.F., Stamm E., Wagenknecht L.E., Rich S.S. Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods. Ann. Epidemiol. 2003, 13:211-217.
23. Steil G.M., Volund A., Kahn S.E., Bergman R.N. Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model. Suitability for use in population studies. Diabetes 1993, 42:250-256.
24. Bergman R.N., Finegood D.T., Ader M. Assessment of insulin sensitivity in vivo. Endocr. Rev. 1985, 6:45-86.
25. Bowden D.W., An S.S., Palmer N.D., Brown W.M., Norris J.M., Haffner S.M., Hawkins G.A., Guo X., Rotter J.I., Chen Y.D., Wagenknecht L.E., Langefeld C.D. Molecular basis of a linkage peak: exome sequencing and family-based analysis identify a rare genetic variant in the ADIPOQ gene in the IRAS Family Study. Hum. Mol. Genet. 2010, 19:4112-4120.
26. Kita A., Yamasaki H., Kuwahara H., Moriuchi A., Fukushima K., Kobayashi M., Fukushima T., Takahashi R., Abiru N., Uotani S., Kawasaki E., Eguchi K. Identification of the promoter region required for human adiponectin gene transcription: association with CCAAT/enhancer binding protein-beta and tumor necrosis factor-alpha. Biochem. Biophys. Res. Commun. 2005, 331:484-490.
27. Willer C.J., Speliotes E.K., Loos R.J., Li S., Lindgren C.M., Heid I.M., Berndt S.I., Elliott A.L., Jackson A.U., Lamina C., Lettre G., Lim N., Lyon H.N., McCarroll S.A., Papadakis K., Qi L., Randall J.C., Roccasecca R.M., Sanna S., Scheet P., Weedon M.N., Wheeler E., Zhao J.H., Jacobs L.C., Prokopenko I., Soranzo N., Tanaka T., Timpson N.J., Almgren P., Bennett A., Bergman R.N., Bingham S.A., Bonnycastle L.L., Brown M., Burtt N.P., Chines P., Coin L., Collins F.S., Connell J.M., Cooper C., Smith G.D., Dennison E.M., Deodhar P., Elliott P., Erdos M.R., Estrada K., Evans D.M., Gianniny L., Gieger C., Gillson C.J., Guiducci C., Hackett R., Hadley D., Hall A.S., Havulinna A.S., Hebebrand J., Hofman A., Isomaa B., Jacobs K.B., Johnson T., Jousilahti P., Jovanovic Z., Khaw K.T., Kraft P., Kuokkanen M., Kuusisto J., Laitinen J., Lakatta E.G., Luan J., Luben R.N., Mangino M., McArdle W.L., Meitinger T., Mulas A., Munroe P.B., Narisu N., Ness A.R., Northstone K., O'Rahilly S., Purmann C., Rees M.G., Ridderstrale M., Ring S.M., Rivadeneira F., Ruokonen A., Sandhu M.S., Saramies J., Scott L.J., Scuteri A., Silander K., Sims M.A., Song K., Stephens J., Stevens S., Stringham H.M., Tung Y.C., Valle T.T., Van Duijn C.M., Vimaleswaran K.S., Vollenweider P., Waeber G., Wallace C., Watanabe R.M., Waterworth D.M., Watkins N., Witteman J.C., Zeggini E., Zhai G., Zillikens M.C., Altshuler D., Caulfield M.J., Chanock S.J., Farooqi I.S., Ferrucci L., Guralnik J.M., Hattersley A.T., Hu F.B., Jarvelin M.R., Laakso M., Mooser V., Ong K.K., Ouwehand W.H., Salomaa V., Samani N.J., Spector T.D., Tuomi T., Tuomilehto J., Uda M., Uitterlinden A.G., Wareham N.J., Deloukas P., Frayling T.M., Groop L.C., Hayes R.B., Hunter D.J., Mohlke K.L., Peltonen L., Schlessinger D., Strachan D.P., Wichmann H.E., McCarthy M.I., Boehnke M., Barroso I., Abecasis G.R., Hirschhorn J.N. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat. Genet. 2009, 41:25-34.
28. Waki H., Yamauchi T., Kamon J., Ito Y., Uchida S., Kita S., Hara K., Hada Y., Vasseur F., Froguel P., Kimura S., Nagai R., Kadowaki T. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J. Biol. Chem. 2003, 278:40352-40363.
29. Beaulieu M. Multiplexing the Homogeneous MassEXTEND Assay. Application Note 2003.
30. O'Connell J.R., Weeks D.E. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am. J. Hum. Genet. 1998, 63:259-266.
31. Almasy L., Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am. J. Hum. Genet. 1998, 62:1198-1211.
32. Palmer N.D., Mychaleckyj J.C., Langefeld C.D., Ziegler J.T., Williams A.H., Bryer-Ash M., Bowden D.W. Evaluation of DLG2 as a positional candidate for disposition index in African-Americans from the IRAS Family Study. Diabetes Res. Clin. Pract. 2010, 87:69-76.
33. Palmer N.D., Langefeld C.D., Ziegler J.T., Hsu F., Haffner S.M., Fingerlin T., Norris J.M., Chen Y.I., Rich S.S., Haritunians T., Taylor K.D., Bergman R.N., Rotter J.I., Bowden D.W. Candidate loci for insulin sensitivity and disposition index from a genome-wide association analysis of Hispanic participants in the Insulin Resistance Atherosclerosis (IRAS) Family Study. Diabetologia 2010, 53:281-289.
34. Ukkola O., Santaniemi M., Rankinen T., Leon A.S., Skinner J.S., Wilmore J.H., Rao D.C., Bergman R., Kesaniemi Y.A., Bouchard C. Adiponectin polymorphisms, adiposity and insulin metabolism: HERITAGE family study and Oulu diabetic study. Ann. Med. 2005, 37:141-150.
35. Morandi A., Maffeis C., Lobbens S., Bouatia-Naji N., Heude B., Pinelli L., Meyre D., Froguel P. Early detrimental metabolic outcomes of rs17300539-A allele of ADIPOQ gene despite higher adiponectinemia. Obesity (Silver Spring) 2010, 18:1469-1473.
36. Yatagai T., Nagasaka S., Taniguchi A., Fukushima M., Nakamura T., Kuroe A., Nakai Y., Ishibashi S. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 2003, 52:1274-1278.
37. Yamamoto Y., Hirose H., Saito I., Nishikai K., Saruta T. Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: two-year follow-up study in Japanese population. J. Clin. Endocrinol. Metab. 2004, 89:87-90.
38. Kim S.Y., Lee S.J., Park H.K., Yun J.E., Lee M., Sung J., Jee S.H. Adiponectin is associated with impaired fasting glucose in the non-diabetic population. Epidemiol. Health 2011, 33:e2011007.
39. Ryo M., Nakamura T., Kihara S., Kumada M., Shibazaki S., Takahashi M., Nagai M., Matsuzawa Y., Funahashi T. Adiponectin as a biomarker of the metabolic syndrome. Circ. J. 2004, 68:975-981.
40. Hanley A.J., Bowden D., Wagenknecht L.E., Balasubramanyam A., Langfeld C., Saad M.F., Rotter J.I., Guo X., Chen Y.D., Bryer-Ash M., Norris J.M., Haffner S.M. Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans. J. Clin. Endocrinol. Metab. 2007, 92:2665-2671.